ACE and type 2 diabetes mellitus: RAAS inhibitors. RAAS inhibitors, including ACE inhibitors and angiotensin receptor blockers, remain the cornerstone of nephroprotection in T2DM by mitigating glomerular hypertension, proteinuria, and fibrosis.